From October 1, 2022 to December 30, 2022, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 1,999,800 shares, representing 5% of its issued share capital under the buyback announced on December 30, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2 CAD | 0.00% |
|
+2.56% | -83.33% |
28/06 | FSD Pharma $2 Million Arbitration Award Upheld by Federal Court Against Former CEO | MT |
28/06 | Sector Update: Health Care Stocks Decline in Late Afternoon Trading | MT |
1st Jan change | Capi. | |
---|---|---|
-83.33% | 69.86L | |
+20.63% | 13TCr | |
+23.21% | 12TCr | |
+25.68% | 2.77TCr | |
-20.17% | 2.03TCr | |
-16.87% | 1.68TCr | |
-18.07% | 1.56TCr | |
+11.92% | 1.48TCr | |
-47.70% | 1.46TCr | |
+58.32% | 1.44TCr |
- Stock Market
- Equities
- HUGE Stock
- News FSD Pharma Inc.
- Tranche Update on FSD Pharma Inc.'s Equity Buyback Plan announced on December 30, 2021.